He was sent to [**Hospital1 18**] for further evaluation on [**2166-12-22**], on [**2166-12-23**] he underwent ERCP with sphincterotomy and CBD stent given marked intra- and extra-hepatic biliary dilatation.
He had tolerated the procedure well and was transferred to OMED service for further diagnostic and therapeutic workup.
Patient was hemodynamically was started on PPI drip.
Successful coil embolization of distal gastroduodenal artery from the SMA where contrast extravasation was seen during diagnostic arteriography indicating active bleeding.
B cell lymphoma: Biopsies from ERCP came back as diffuse large B-cell lymphoma.
Patient stated Cycle 1 [**Hospital1 **] - 50% dose reduction of Etoposide, Vincristine, Doxorubicin, Full dose Cytoxan and Prednisone.
Tolerated chemotherapy well with no complications.
Neupogen 480 mcg/0.8 mL Syringe Sig: One (1)  Injection once a day.
Fluticasone 50 mcg/Actuation Spray, Suspension Sig: Two (2) Spray Nasal DAILY (Daily).
Omeprazole 40 mg Capsule, Delayed Release(E.C.)
Fluticasone 110 mcg/Actuation Aerosol Sig: Two (2) Puff Inhalation [**Hospital1 **] (2 times a day).
Trimethoprim-Sulfamethoxazole 80-400 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
You underwent an ERCP with sphincterotomy and a common bile duct stent was placed.
Following the procedure you suffered a GI bleed and the source was catheterized in interventional radiology.
The mass in your abdomen was diagnosed as large B cell lymphoma and you were started on chemotherapy called [**Hospital1 **].
You received your first cycle during this hospitalization and tolerated the chemotherapy treatment very well.
You are being discharged on new medication, please review your medications closely.
